3-184353297-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004366.6(CLCN2):​c.1981T>A​(p.Ser661Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000803 in 1,613,758 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S661P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0042 ( 3 hom., cov: 31)
Exomes 𝑓: 0.00045 ( 11 hom. )

Consequence

CLCN2
NM_004366.6 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0480

Publications

3 publications found
Variant links:
Genes affected
CLCN2 (HGNC:2020): (chloride voltage-gated channel 2) This gene encodes a voltage-gated chloride channel. The encoded protein is a transmembrane protein that maintains chloride ion homeostasis in various cells. Defects in this gene may be a cause of certain epilepsies. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]
CLCN2 Gene-Disease associations (from GenCC):
  • leukoencephalopathy with mild cerebellar ataxia and white matter edema
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • epilepsy, idiopathic generalized, susceptibility to, 11
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • familial hyperaldosteronism type II
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035895407).
BP6
Variant 3-184353297-A-T is Benign according to our data. Variant chr3-184353297-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377181.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00416 (634/152248) while in subpopulation AFR AF = 0.0142 (592/41550). AF 95% confidence interval is 0.0133. There are 3 homozygotes in GnomAd4. There are 305 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCN2NM_004366.6 linkc.1981T>A p.Ser661Thr missense_variant Exon 17 of 24 ENST00000265593.9 NP_004357.3 P51788-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCN2ENST00000265593.9 linkc.1981T>A p.Ser661Thr missense_variant Exon 17 of 24 1 NM_004366.6 ENSP00000265593.4 P51788-1

Frequencies

GnomAD3 genomes
AF:
0.00415
AC:
631
AN:
152130
Hom.:
3
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00105
AC:
264
AN:
251298
AF XY:
0.000810
show subpopulations
Gnomad AFR exome
AF:
0.0144
Gnomad AMR exome
AF:
0.000491
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000616
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000453
AC:
662
AN:
1461510
Hom.:
11
Cov.:
36
AF XY:
0.000386
AC XY:
281
AN XY:
727096
show subpopulations
African (AFR)
AF:
0.0161
AC:
538
AN:
33480
American (AMR)
AF:
0.000671
AC:
30
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53066
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000180
AC:
20
AN:
1111988
Other (OTH)
AF:
0.00111
AC:
67
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
42
84
127
169
211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00416
AC:
634
AN:
152248
Hom.:
3
Cov.:
31
AF XY:
0.00410
AC XY:
305
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0142
AC:
592
AN:
41550
American (AMR)
AF:
0.00209
AC:
32
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67992
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
32
65
97
130
162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000246
Hom.:
1
Bravo
AF:
0.00482
ESP6500AA
AF:
0.0102
AC:
45
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00130
AC:
158
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000296

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CLCN2: BP4, BS1, BS2 -

Sep 02, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
0.22
DANN
Benign
0.80
DEOGEN2
Benign
0.14
T;.;.;.
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.038
N
LIST_S2
Benign
0.59
T;T;T;T
MetaRNN
Benign
0.0036
T;T;T;T
MetaSVM
Benign
-0.79
T
MutationAssessor
Benign
0.85
L;.;.;L
PhyloP100
-0.048
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.84
N;N;N;N
REVEL
Benign
0.067
Sift
Benign
0.096
T;T;T;T
Sift4G
Benign
0.58
T;T;T;T
Polyphen
0.38
B;P;.;.
Vest4
0.10
MVP
0.73
MPC
0.27
ClinPred
0.00031
T
GERP RS
0.82
Varity_R
0.035
gMVP
0.37
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115380062; hg19: chr3-184071085; API